| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/25/2006 | EP1617723A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof |
| 01/25/2006 | EP1151121B1 Recombined porcine adenovirus based viral vaccines and vectors |
| 01/25/2006 | EP1062325B1 Purification of virus preparations |
| 01/25/2006 | CN1726276A Production of ALVAC on avian embryonic stem cells |
| 01/25/2006 | CN1724565A Barley yellow dwarf virus mediator ophid body and toxin transmission related protein and its application |
| 01/25/2006 | CN1238500C Immunology epitope of hog cholera virus feature and application thereof |
| 01/25/2006 | CN1237873C Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temp. storage by drying |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/24/2006 | US6989263 Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| 01/24/2006 | US6989258 DNA encoding a plant deoxyhpusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 01/19/2006 | WO2004100640A3 Marek’s disease virus vaccine |
| 01/19/2006 | WO2004042001A3 Virus-like particles, methods of preparation, and immonogenic compositions |
| 01/19/2006 | US20060014276 Chimeric adenoviruses |
| 01/19/2006 | US20060014140 Molecular methods and compositions for detecting and quantifying respiratory viruses |
| 01/19/2006 | US20060013828 Isolated avirulent form of a carp virus, a double stranded DNA virus having a capsid with a icosahedron morphology and being of 90-110 nm in size and having 250,000 - 300,000 base pairs; causative agent of the disease affecting Cyprinus carpino; fish vaccines |
| 01/19/2006 | US20060013826 Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions |
| 01/19/2006 | US20060013797 N-maleimidyl polymer derivatives |
| 01/19/2006 | DE102004025452A1 Vakzine enthaltend BVDV Vaccine containing BVDV |
| 01/19/2006 | CA2583081A1 Multichemistry fractionation |
| 01/18/2006 | EP1616961A1 Vectors and methods for gene transfer to cells |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1395676B1 Viral drug susceptibility testing |
| 01/18/2006 | EP1100925B1 Attenuated equine herpesvirus |
| 01/18/2006 | CN1721526A Method for removing the activity of coronavirus by using supercritical fluid |
| 01/18/2006 | CN1237178C Use and constructing plan of anticancer recombined gland virus with tumour CHK1 as target of medicine |
| 01/18/2006 | CN1237177C Use and obtain of selective inactivating tumour PLK1 anticancer recombined gland virus constituent |
| 01/18/2006 | CN1236818C Caprine arthritis-encephalitis virus provided immunoprotection against HIV-1 infection |
| 01/12/2006 | WO2006004878A1 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |
| 01/12/2006 | US20060008820 Cell cycle genes in plants |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008473 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2006 | US20060008469 Infectious clone of human parvovirus B19 and methods |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/11/2006 | EP1614423A2 Attenuated pestiviruses |
| 01/11/2006 | EP1613660A2 Compositions and methods relating to stop-1 |
| 01/11/2006 | EP1407033B1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | EP0764210B1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 01/11/2006 | CN1720262A Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 01/11/2006 | CN1236057C Recombinant gland related virus expressing human kallikrein, its preparation method and application |
| 01/10/2006 | US6984728 Recombinant infectious laryngotracheitis virus for use as tool in prevention of viral infections |
| 01/10/2006 | US6984504 Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons |
| 01/10/2006 | US6984386 Nanoparticle covering with non-plant virion coat protein shell; prepare by incubation, adjusting PH, control opening an entry on virion to confine, trap the mineral inside; magnetic resonance imaging, contrasting agents, drug delivery |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/09/2006 | CA2474032A1 Infectious clone of human parvovirus b19 and methods |
| 01/05/2006 | WO2005103237A9 Method of constructing recombinant herpes simplex virus |
| 01/05/2006 | WO2004025267A3 Method for testing drug susceptibility of hiv |
| 01/05/2006 | US20060003453 High-efficiency AAV helper functions |
| 01/05/2006 | US20060003451 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 01/05/2006 | US20060003444 Cells for detection of influenza and parainfluenza viruses |
| 01/05/2006 | US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 01/05/2006 | US20060003340 Multi-allelic molecular detection of SARS-associated coronavirus |
| 01/05/2006 | US20060003314 Methods for peptide and protein display in nucleic acid arrays |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/05/2006 | US20060002896 Method of generating recombinant MVA |
| 01/05/2006 | US20060002894 Method for introducing a biological molecule using a viral envelope and composition and system therefor |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | DE19825129B4 Verwendung von nukleinsäurefreien Viruspartikeln und Proteinen als Schmiermittel und zur Bildung von Komplexen mit Fullerenen Use of nucleic acid free viral particles and proteins, as a lubricant and to the formation of complexes with fullerenes |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | CN1717480A Improvements in virus production |
| 01/04/2006 | CN1234852C False virosome vaccine with recombinant replica of dengue fever virus as carrier |
| 01/04/2006 | CN1234851C Vaccine for human papilloma virus |
| 01/03/2006 | US6982160 Immunogenic compositions that include SIRS virus |
| 01/03/2006 | US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 12/29/2005 | WO2005123910A1 Hbv particles containing hbv-rna |
| 12/29/2005 | WO2005123773A1 Method for site-directed immunisation |
| 12/29/2005 | WO2005098009A3 Synergistic attenutation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 12/29/2005 | WO2005072364A3 A modified baculovirus expression system for production of pseudotyped raav vector |
| 12/29/2005 | WO2005053516A3 Replication competent hepatitis c virus and methods of use |
| 12/29/2005 | WO2005040353A3 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 12/29/2005 | WO2005040352A3 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 12/29/2005 | WO2005020889A3 Functional influenza virus-like particles (vlps) |
| 12/29/2005 | WO2005013918A3 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 12/29/2005 | WO2004069166A3 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 12/29/2005 | US20050287662 Helper-free stocks of recombinant adeno-associated virus vectors |
| 12/29/2005 | US20050287657 Method for producing recombinant adenovirus |
| 12/29/2005 | US20050287540 Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
| 12/29/2005 | US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 12/29/2005 | US20050287514 Compositions and methods useful for HCV infection |
| 12/29/2005 | US20050287172 Influenza hemagglutinin and neuraminidase variants |
| 12/29/2005 | US20050287171 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 12/29/2005 | US20050287162 Recombinant fowlpox virus |
| 12/29/2005 | US20050287120 Cancer - targeted viral vectors |
| 12/29/2005 | US20050287116 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 12/28/2005 | EP1609865A2 Hepatitis B virus (HBV) variants |
| 12/28/2005 | EP1608762A2 Improved alphavirus replicons and helper constructs |
| 12/28/2005 | EP1608741A2 Infectious bursal disease virus mutants and vaccines |
| 12/28/2005 | EP1608683A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
| 12/28/2005 | EP1608393A2 Ebola peptides and immunogenic compositions containing same |
| 12/28/2005 | EP1608384A2 Therapy for primary and metastatic cancers |
| 12/28/2005 | EP1335987B1 Modified vaccinia ankara virus variant |
| 12/28/2005 | EP1123114B1 Virus-like particles for the induction of autoantibodies |
| 12/28/2005 | EP1021544B1 Chimeric vaccine against tick-borne encephalitis virus |
| 12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
| 12/28/2005 | EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 12/28/2005 | CN1714148A Viral deconstruction through capsid assembly in vitro |